BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2192104)

  • 1. [Clinical significance of ST 272 Ag detected by the monoclonal antibody, NCC-ST-272].
    Sekine T
    Nihon Rinsho; 1990 Feb; 48 Suppl():1028-30. PubMed ID: 2192104
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical significance of NCC-ST-439 antigen assay detected by the monoclonal antibody as a tumor marker].
    Sugano K; Okura H
    Nihon Rinsho; 1990 Feb; 48 Suppl():1031-4. PubMed ID: 2192105
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical significance of CA 195 assay as a tumor marker].
    Ohkura H; Sakawaki T
    Nihon Rinsho; 1990 Feb; 48 Suppl():982-4. PubMed ID: 2355639
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical significance of TAC-41 assay as a tumor marker].
    Ariyoshi Y; Kuwabara M; Iwakoshi N; Kito K
    Nihon Rinsho; 1990 Feb; 48 Suppl():1060-3. PubMed ID: 2162412
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical significance of YH-206 assay analysis as a tumor marker].
    Yachi A; Hinoda Y; Imai K; Endo T
    Nihon Rinsho; 1990 Feb; 48 Suppl():1068-70. PubMed ID: 2192107
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical significance of pancreatic oncofetal antigen, pancreatic cancer associated antigen assay as tumor markers].
    Shimano T; Morimoto H; Saito M; Mori T
    Nihon Rinsho; 1990 Feb; 48 Suppl():917-9. PubMed ID: 2192174
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study on the clinical usefulness of NCC-ST-439 in cases of digestive tract cancer].
    Anzai K; Kurihara M; Izumi T
    Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1437-47. PubMed ID: 2212836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of CA 50 assay as a tumor marker].
    Hara K; Mitsuhashi F; Ohkura H
    Nihon Rinsho; 1990 Feb; 48 Suppl():971-3. PubMed ID: 2192182
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical study of the NCC-ST-439 EIA kit using serum from patients with various types of cancer and benign disease (1)].
    Ohkura H; Hattori N; Miyazaki I; Sawabu N; Tobe R; Kawai K; Abe O; Ishii M; Kawai T; Kamano T
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1901-6. PubMed ID: 2439020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of KMO1 for the gastrointestinal disease].
    Okumura S; Ohyanagi H; Saitoh Y
    Nihon Rinsho; 1990 Feb; 48 Suppl():1017-21. PubMed ID: 2192103
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical significance of CA 72-4 assay as a tumor marker].
    Konishi F
    Nihon Rinsho; 1990 Feb; 48 Suppl():974-7. PubMed ID: 2355638
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical study of the NCC-ST-439 EIA kit using serum from patients with various types of cancer and benign disease (2)].
    Ohkura H; Hattori N; Miyazaki I; Sawabu N; Tobe R; Kawai K; Abe O; Ishii M; Kawai T; Kamano T
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1907-12. PubMed ID: 2439021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CA72-4 (TAG-72)].
    Maida Y; Kyo S; Inoue M
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():672-4. PubMed ID: 16149608
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tumor markers in the upper intestinal tract--stomach and pancreas].
    Pointner R; Conrad F; Schwab G
    Wien Klin Wochenschr; 1989 Jul; 101(14):482-4. PubMed ID: 2773485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of serum NCC-ST 439 as a tumor marker for colorectal cancer].
    Yamaguchi A; Kurosaka Y; Ohta N; Kamata T; Ishida T; Nishimura G; Katoh M; Kosaka T; Yonemura Y; Miyazaki I
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2645-50. PubMed ID: 2549882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of DU-PAN-2 analysis as a tumor marker].
    Sawabu N; Satomura Y
    Nihon Rinsho; 1990 Feb; 48 Suppl():1003-7. PubMed ID: 2162408
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor markers in pancreatic cancer--current concepts.
    Schmiegel W
    Hepatogastroenterology; 1989 Dec; 36(6):446-9. PubMed ID: 2693300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tumor markers in hepatoma, gallbladder-biliary tract and pancreas cancer].
    Nakahara M; Fujisawa K
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3010-9. PubMed ID: 2445292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study of pancreatic cystadenocarcinoma.
    Motojima K; Tomioka T; Tsunoda T; Kanamatsu T
    Am J Gastroenterol; 1992 Jan; 87(1):43-7. PubMed ID: 1728123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of cancer-associated antigen in feces of patients with gastric cancer by monoclonal antibodies].
    Yuan M
    Zhonghua Zhong Liu Za Zhi; 1991 Mar; 13(2):103-5. PubMed ID: 1879286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.